Harvard Apparatus Regenerative Technology (HRGN) has released an update to notify the public and investors about an entry into a material definitive agreement.
Harvard Apparatus Regenerative Technology, Inc. has secured a $500,000 bridge loan from its CEO Junli He, with an 8% annual interest rate. This loan is set to mature on the earlier of two events: either the company’s next significant capital raise of at least $5 million or by February 1, 2025. The agreement includes an optional conversion feature, standard covenants, and default terms to protect the lender’s interests.
For further insights into HRGN stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
